GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biotika AS (XBRA:1BSL01AE) » Definitions » Gross Margin %

Biotika AS (XBRA:1BSL01AE) Gross Margin % : 36.78% (As of Jun. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Biotika AS Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Biotika AS's Gross Profit for the six months ended in Jun. 2023 was €3.41 Mil. Biotika AS's Revenue for the six months ended in Jun. 2023 was €9.28 Mil. Therefore, Biotika AS's Gross Margin % for the quarter that ended in Jun. 2023 was 36.78%.


The historical rank and industry rank for Biotika AS's Gross Margin % or its related term are showing as below:

XBRA:1BSL01AE' s Gross Margin % Range Over the Past 10 Years
Min: 33.25   Med: 41.19   Max: 68.53
Current: 36.78


During the past 13 years, the highest Gross Margin % of Biotika AS was 68.53%. The lowest was 33.25%. And the median was 41.19%.

XBRA:1BSL01AE's Gross Margin % is ranked worse than
67.85% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.51 vs XBRA:1BSL01AE: 36.78

Biotika AS had a gross margin of 36.78% for the quarter that ended in Jun. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Biotika AS was 8.20% per year.


Biotika AS Gross Margin % Historical Data

The historical data trend for Biotika AS's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotika AS Gross Margin % Chart

Biotika AS Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.87 48.94 50.78 68.53 46.02

Biotika AS Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.65 63.73 46.02 - 36.78

Competitive Comparison of Biotika AS's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Biotika AS's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotika AS's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biotika AS's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Biotika AS's Gross Margin % falls into.



Biotika AS Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Biotika AS's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=5.1 / 11.03
=(Revenue - Cost of Goods Sold) / Revenue
=(11.03 - 5.954) / 11.03
=46.02 %

Biotika AS's Gross Margin for the quarter that ended in Jun. 2023 is calculated as


Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=3.4 / 9.275
=(Revenue - Cost of Goods Sold) / Revenue
=(9.275 - 5.864) / 9.275
=36.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Biotika AS  (XBRA:1BSL01AE) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Biotika AS had a gross margin of 36.78% for the quarter that ended in Jun. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Biotika AS Gross Margin % Related Terms

Thank you for viewing the detailed overview of Biotika AS's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotika AS (XBRA:1BSL01AE) Business Description

Traded in Other Exchanges
N/A
Address
Slovenskc Lupca 566, Banská Bystrica, SVK, 976 13
Biotika AS is a manufacturer of pharmaceutical preparations for the human and veterinary application. It is engaged in the production of Active Pharmaceutical Ingredients (API), contract manufacturing of API, and contract manufacturing of final dosage formulations. It also offers research and development services. It manufacturers Polymyxine B Sulfate and other API for third parties (toll manufacturing) of pharmaceutical quality. Biotika is well known as a reliable manufacturer of high-quality pharmaceutical preparations for the human as well as veterinary application and also as a very important producer of the feed additives for breeding farm animals.

Biotika AS (XBRA:1BSL01AE) Headlines

No Headlines